AAAAAA

   
Results: 1-12 |
Results: 12

Authors: SAKAGUCHI K HERRERA JE SAITO S MIKI T BUSTIN M VASSILEV A ANDERSON CW APPELLA E
Citation: K. Sakaguchi et al., DNA-DAMAGE ACTIVATES P53 THROUGH A PHOSPHORYLATION-ACETYLATION CASCADE, Genes & development, 12(18), 1998, pp. 2831-2841

Authors: POSTNIKOV YV HERRERA JE HOCK R SCHEER U BUSTIN M
Citation: Yv. Postnikov et al., CLUSTERS OF NUCLEOSOMES CONTAINING CHROMOSOMAL PROTEIN HMG-17 IN CHROMATIN, Journal of Molecular Biology, 274(4), 1997, pp. 454-465

Authors: HERRERA JE BERGEL M YANG XJ NAKATANI Y BUSTIN M
Citation: Je. Herrera et al., THE HISTONE ACETYLTRANSFERASE ACTIVITY OF HUMAN GCN5 AND PCAF IS STABILIZED BY COENZYMES, The Journal of biological chemistry, 272(43), 1997, pp. 27253-27258

Authors: CASTANEDAHERNANDEZ G FLORESMURRIETA FJ GRANADOSSOTO V HERRERAABARCA A PEREZURIZAR J HERRERA JE HONG E
Citation: G. Castanedahernandez et al., PHARMACOKINETICS OF ORAL RANITIDINE IN MEXICANS, Archives of medical research, 27(3), 1996, pp. 349-352

Authors: HERRERA JE CORREIA JJ JONES AE OLSON MOJ
Citation: Je. Herrera et al., SEDIMENTATION ANALYSES OF THE SALT-INDUCED AND DIVALENT METAL ION-INDUCED OLIGOMERIZATION OF NUCLEOLAR PROTEIN B23, Biochemistry, 35(8), 1996, pp. 2668-2673

Authors: CASTANEDAHERNANDEZ G HOYOVADILLO C HERRERA JE
Citation: G. Castanedahernandez et al., DIFFERENCES IN NIFEDIPINE CONCENTRATION-EFFECT RELATIONSHIP BETWEEN CAPSULE AND SLOW-RELEASE TABLET ADMINISTRATION, International journal of clinical pharmacology and therapeutics, 33(1), 1995, pp. 56-60

Authors: HERRERA JE SAVKUR R OLSON MOJ
Citation: Je. Herrera et al., THE RIBONUCLEASE-ACTIVITY OF NUCLEOLAR PROTEIN B23, Nucleic acids research, 23(19), 1995, pp. 3974-3979

Authors: SZEBENI A HERRERA JE OLSON MOJ
Citation: A. Szebeni et al., INTERACTION OF NUCLEOLAR PROTEIN B23 WITH PEPTIDES RELATED TO NUCLEAR-LOCALIZATION SIGNALS, Biochemistry, 34(25), 1995, pp. 8037-8042

Authors: FLORESMURRIETA FJ GRANADOSSOTO V CASTANEDAHERNANDEZ G HERRERA JE HONG E
Citation: Fj. Floresmurrieta et al., COMPARATIVE BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF KETOROLAC TROMETHAMINE - DOLAC(R) AND EXODOL(R), Biopharmaceutics & drug disposition, 15(2), 1994, pp. 129-136

Authors: ELIZONDO G MONTERO R HERRERA JE HONG E OSTROSKYWEGMAN P
Citation: G. Elizondo et al., LYMPHOCYTE-PROLIFERATION KINETICS AND SISTER-CHROMATID EXCHANGES IN INDIVIDUALS TREATED WITH METRONIDAZOLE, MUTATION RESEARCH, 305(2), 1994, pp. 133-137

Authors: HERRERA JE CHAIRES JB
Citation: Je. Herrera et Jb. Chaires, CHARACTERIZATION OF PREFERRED DEOXYRIBONUCLEASE-I CLEAVAGE SITES, Journal of Molecular Biology, 236(2), 1994, pp. 405-411

Authors: SCOTT GJ HERRERA JE
Citation: Gj. Scott et Je. Herrera, SIMPLE PROCESSING OF FARM PRODUCES - METH ODS FOR FEASIBILITY EVALUATION, Archivos latinoamericanos de nutricion, 43(2), 1993, pp. 105-118
Risultati: 1-12 |